Tumor Size Predicts Vascular Invasion and Histologic Grade Among Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma

Journal of Gastrointestinal Surgery

Volumn 18, Issue 7, 2014, Pages 1284-1291

  Spolverato, Gaya ^a   Ejaz, Aslam ^a   Kim, Yuhree ^a   Sotiropoulos, Georgios C ^b   Pau, Andreas ^b   Alexandrescu, Sorin ^c   Marques, Hugo ^d   Pulitano, Carlo ^e   Barroso, Eduardo ^d   Clary, Bryan M ^f   Aldrighetti, Luca ^e   Bauer, Todd W ^g   Walters, Dustin M ^g   Groeschl, Ryan ^h   Gamblin, T Clark ^h   Marsh, Wallis ⁱ   Nguyen, Kevin T ⁱ   Turley, Ryan ^f   Popescu, Irinel ^c   Hubert, Catherine ^j   Meyer, Stephanie ^k   Gigot, Jean Francois ^j   Mentha, Gilles ^k   Pawlik, Timothy M ^a,l   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Institute for Digestive Diseases and Liver Transplantation Fundeni   (Romania)

^d HOSPITAL CURRY CABRAL   (Portugal)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ UNIVERSITY OF PITTSBURGH   (United States)

^j CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^k GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^l JOHNS HOPKINS HOSPITAL   (United States)

more..

Author keywords

Intrahepatic cholangiocarcinoma; Tumor size; Vascular invasion

Indexed keywords

AGED; ANALYSIS OF VARIANCE; BILE DUCT NEOPLASMS; CANCER STAGING; CHOLANGIOCARCINOMA; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; INTRAHEPATIC BILE DUCT; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME; TUMOR INVASION; TUMOR VOLUME; VASCULARIZATION;

AGED; ANALYSIS OF VARIANCE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84902532528     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-014-2533-1     Document Type: Article

References (21)

1. El-Serag HB, Engels EA, Landgren O, Chiao E, Henderson L, Amaratunge HC, Giordano TP: Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of U. S. veterans. Hepatology 2009, 49(1): 116-123.
2. Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L et al.: Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Annals of Surgery 2008, 248(1): 84-96.
3. Malhi H, Gores GJ: Cholangiocarcinoma: modern advances in understanding a deadly old disease. Journal of Hepatology 2006, 45(6): 856-867.
4. Shaib YH, Davila JA, McGlynn K, El-Serag HB: Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? Journal of Hepatology 2004, 40(3): 472-477.
5. Welzel TM, McGlynn KA, Hsing AW, O'Brien TR, Pfeiffer RM: Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. Journal of the National Cancer Institute 2006, 98(12): 873-875.
6. Khan SA, Toledano MB, Taylor-Robinson SD: Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma. HPB (Oxford) 2008, 10(2): 77-82.
7. de Jong MC, Nathan H, Sotiropoulos GC, Paul A, Alexandrescu S, Marques H, Pulitano C, Barroso E, Clary BM, Aldrighetti L et al. 2011: Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. Journal of Clinical Oncology 29(23): 3140-3145.
8. Greene FL PD, Flemming ID, Friitz A, Balch CM, Heller DG, et al.: AJCC cancer staging manual. 6th ed.; 2002.
9. Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, Choti MA, Pawlik TM: a proposed staging system for intrahepatic cholangiocarcinoma. Annals of Surgical Oncology 2009, 16(1): 14-22.
10. Okabayashi T, Yamamoto J, Kosuge T, Shimada K, Yamasaki S, Takayama T, Makuuchi M: A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables. Cancer 2001, 92(9): 2374-2383.
11. Yamasaki S: Intrahepatic cholangiocarcinoma: macroscopic type and stage classification. Journal of Hepato-Biliary-Pancreatic Surgery 2003, 10(4): 288-291.
12. Edge SBD, Compton C, Fritz A, Greene F, Trotti A: AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2010.
13. Hyder O, Marques H, Pulitano C, Marsh JW, Alexandrescu S, Bauer TW, Gamblin TC, Sotiropoulos GC, Paul A, Barroso E et al.: A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an eastern and western experience. JAMA surgery 2014.
14. Brennan MF, Kattan MW, Klimstra D, Conlon K: Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Annals of Surgery 2004, 240(2): 293-298.
15. Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT et al.: Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transplantation 2005, 11(9): 1086-1092.
16. Compton CC, American Joint Committee on Cancer.: AJCC cancer staging atlas: a companion to the seventh editions of the AJCC cancer staging manual and handbook, 2nd edn.
17. Liu ZH, Chen Z, Ma LL, Li XH, Wang LX: Factors influencing the prognosis of patients with intrahepatic cholangiocarcinoma. Acta Gastro-enterologica Belgica 2012, 75(2): 215-218.
18. Saxena A, Chua TC, Sarkar A, Chu F, Morris DL: Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. Journal of Gastrointestinal Surgery 2010, 14(7): 1128-1138.
19. Shirabe K, Mano Y, Taketomi A, Soejima Y, Uchiyama H, Aishima S, Kayashima H, Ninomiya M, Maehara Y: Clinicopathological prognostic factors after hepatectomy for patients with mass-forming type intrahepatic cholangiocarcinoma: relevance of the lymphatic invasion index. Annals of Surgical Oncology 2010, 17(7): 1816-1822.
20. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP: Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33(6): 1394-1403.
21. Maithel SK, Gamblin TC, Kamel I, Corona-Villalobos CP, Thomas M, Pawlik TM: Multidisciplinary approaches to intrahepatic cholangiocarcinoma. Cancer 2013, 119(22): 3929-3942.